Medication info
Plavix Tablet (Clopidogrel Bisulfate)

Plavix Tablet (Clopidogrel Bisulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Kukje Pharmaceuticals Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201307537 · Approved 2013.05.29 · Insurance code 643703630

Summary

Main use
Improvement of symptoms of atherosclerotic disease and acute coronary syndrome; prevention of thrombosis in atrial fibrillation
Who takes it
Adults
Adult dose
1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the day this drug is started with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. In this case, administer aspirin 75 ~ 325 mg once daily in combination with this drug. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. In this case, administer aspirin 75 ~ 100 mg once daily in combination with this drug. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease with a bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
Kukje Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerotic disease and acute coronary syndrome; prevention of thrombosis in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular anomalies
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
View approved original text

This medication is used to improve symptoms due to atherosclerosis in adult patients with ischemic stroke, myocardial infarction, and peripheral arterial disease. It also effectively improves atherosclerotic symptoms such as death from cardiovascular anomalies, myocardial infarction, and stroke in adult patients with acute coronary syndrome who have undergone drug treatment, coronary intervention, or coronary artery bypass grafting. Additionally, it helps reduce the risk of atherothrombosis and thromboembolism, such as stroke, in patients with atrial fibrillation who have vascular risk factors and where vitamin K antagonists are inappropriate and the risk of bleeding is low. This medication is useful in preventing cardiovascular and vascular-related complications and improving symptoms.

How to take

Adult dose

1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the day this drug is started with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. In this case, administer aspirin 75 ~ 325 mg once daily in combination with this drug. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. In this case, administer aspirin 75 ~ 100 mg once daily in combination with this drug. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease with a bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication prevents platelets from aggregating, thereby preventing blood clotting. Individuals with a genetic deficiency in the specific enzyme (CYP2C19) may have reduced effectiveness of this medication; alternative treatment options should be considered in such cases. Additionally, caution is advised if this medication is taken in combination with drugs that activate the CYP2C19 enzyme, as this can increase the risk of bleeding due to excessive efficacy. Patients allergic to this medication or its ingredients, those with bleeding disorders, severely impaired liver function, women who are breastfeeding, or individuals with certain genetic disorders should not use this medication. Patients at high risk of bleeding or those scheduled for surgery should consult with a physician about the need to discontinue or adjust the medication. During treatment, it may be easy to experience bleeding; therefore, if any bleeding symptoms occur, medical personnel should be informed immediately. Extra caution is warranted when taken concurrently with other medications that increase the risk of bleeding. Rarely, prolonged use of this medication may lead to serious blood disorders. Therefore, if any symptoms of infection or abnormal symptoms appear, immediate medical attention should be sought. It is known that there is minimal effect on the fetus during pregnancy; however, the risk of bleeding may increase during delivery, and discontinuation of the medication before childbirth is advisable. If breastfeeding, consult with a physician about whether to continue or discontinue breastfeeding, as this medication may be excreted in breast milk. Safety in children has not been established, and in the elderly, caution is advised due to increased bleeding risk. Overdosing may increase the risk of bleeding; hence, it is crucial to adhere to the prescribed dosage and administration. This medication should be stored out of reach of children and not transferred to another container.

Side effects

Bleeding, gastrointestinal bleeding, hospitalization required for bleeding, purpura, contusion, hematoma, epistaxis, hematuria, intraocular bleeding, intracranial bleeding, significant bleeding, life-threatening bleeding, fatal bleeding, hemorrhagic stroke, need for anticoagulants, need for transfusion, substantial functional impairment, significant vision loss associated with intraocular bleeding, mild bleeding, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, depression, upper respiratory tract infection, shortness of breath, rhinitis, bronchitis, cough, urinary tract infection, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, hypercholesterolemia, arthralgia, low back pain, depression, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, allergic symptoms, ischemic necrosis, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal ulcer bleeding, abdominal distension, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria syndrome, hemoptysis, retroperitoneal bleeding, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, stomatitis, hepatitis, acute liver failure, giant hives, erythematous rash, maculopapular rash, urticaria, pruritus, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, drug rash, lichen planus, arthritis, myalgia, glomerulopathy, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, decreased motor function, tremor, voice disorder, abnormal gait, hyperactivity, ataxia, sensory abnormalities, insomnia, forgetfulness, anxiety, somnolence, psychomotor disturbances, abnormal behavior, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, purpura syndrome, bloody stool, cerebral hemorrhage, hematoma, hemoptysis, muscle bleeding, gum bleeding, anemia, cough, shortness of breath, visual disturbances, vision impairment, dry eyes, transient blindness, congestion, tinnitus, taste disturbances, taste loss, angioedema, renal dysfunction, acute renal failure, cholecystitis, hematemesis, spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is also advisable to store the medication at room temperature, which is between 1 to 30 degrees Celsius, avoiding extreme temperatures.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.